HARVARD MANAGEMENT CO INC Diversified Active

Location: Boston, MA

CIK: 0001082621 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value: $1.844B (100.0% shares, 0.0% debt)

Holdings (30)

RPRX ROYALTY PHARMA PLC 39.9%
Value $735M Shares 14,690,780 Share Price $50.05 Est. Cost/Share — Unrealized @ Report Date —
CRM SALESFORCE COM INC 11.2%
Value $206M Shares 927,541 Share Price $222.53 Est. Cost/Share — Unrealized @ Report Date —
MSFT MICROSOFT CORP 9.9%
Value $183M Shares 821,062 Share Price $222.42 Est. Cost/Share — Unrealized @ Report Date —
ABCL ABCELLERA BIOLOGICS INC 9.0%
Value $165M Shares 4,105,095 Share Price $40.24 Est. Cost/Share — Unrealized @ Report Date —
LNWO SCIENTIFIC GAMES CORP 6.0%
Value $111M Shares 2,678,571 Share Price $41.49 Est. Cost/Share — Unrealized @ Report Date —
META FACEBOOK INC 6.0%
Value $111M Shares 406,540 Share Price $273.16 Est. Cost/Share — Unrealized @ Report Date —
PANW PALO ALTO NETWORKS INC 3.2%
Value $59.42M Shares 167,202 Share Price $355.39 Est. Cost/Share — Unrealized @ Report Date —
— PRAXIS PRECISION MEDICINES I 2.4%
Value $43.61M Shares 792,617 Share Price $55.02 Est. Cost/Share — Unrealized @ Report Date —
QQQ INVESCO QQQ TR 1.9%
Value $35.38M Shares 112,765 Share Price $313.74 Est. Cost/Share — Unrealized @ Report Date —
RVMD REVOLUTION MEDICINES INC 1.4%
Value $26.54M Shares 670,382 Share Price $39.59 Est. Cost/Share — Unrealized @ Report Date —
IVV ISHARES TR 1.3%
Value $24.28M Shares 64,672 Share Price $375.39 Est. Cost/Share — Unrealized @ Report Date —
RLAY RELAY THERAPEUTICS INC 1.2%
Value $22.49M Shares 541,124 Share Price $41.56 Est. Cost/Share — Unrealized @ Report Date —
— KINNATE BIOPHARMA ORD 1.1%
Value $19.81M Shares 498,001 Share Price $39.78 Est. Cost/Share — Unrealized @ Report Date —
GLD SPDR GOLD TR 0.9%
Value $17.23M Shares 96,619 Share Price $178.36 Est. Cost/Share — Unrealized @ Report Date —
— GENERATION BIO CO 0.8%
Value $14.78M Shares 521,460 Share Price $28.35 Est. Cost/Share — Unrealized @ Report Date —
PLRX PLIANT THERAPEUTICS INC 0.7%
Value $12.78M Shares 562,379 Share Price $22.72 Est. Cost/Share — Unrealized @ Report Date —
NRIX NURIX THERAPEUTICS INC 0.6%
Value $10.35M Shares 314,762 Share Price $32.88 Est. Cost/Share — Unrealized @ Report Date —
VEA VANGUARD TAX-MANAGED INTL FD 0.4%
Value $8.216M Shares 174,041 Share Price $47.21 Est. Cost/Share — Unrealized @ Report Date —
— NUCANA PLC 0.4%
Value $7.535M Shares 1,678,239 Share Price $4.49 Est. Cost/Share — Unrealized @ Report Date —
FULC FULCRUM THERAPEUTICS INC 0.3%
Value $4.809M Shares 410,714 Share Price $11.71 Est. Cost/Share — Unrealized @ Report Date —
IJR ISHARES TR 0.2%
Value $4.568M Shares 49,710 Share Price $91.89 Est. Cost/Share — Unrealized @ Report Date —
VWO VANGUARD INTL EQUITY INDEX F 0.2%
Value $4.027M Shares 80,360 Share Price $50.11 Est. Cost/Share — Unrealized @ Report Date —
IJH ISHARES TR 0.2%
Value $3.736M Shares 16,255 Share Price $229.84 Est. Cost/Share — Unrealized @ Report Date —
— SERES THERAPEUTICS INC 0.2%
Value $3.23M Shares 131,847 Share Price $24.50 Est. Cost/Share — Unrealized @ Report Date —
— FS DEV CORP 0.1%
Value $2.75M Shares 250,000 Share Price $11.00 Est. Cost/Share — Unrealized @ Report Date —
— MAGENTA THERAPEUTICS INC 0.1%
Value $2.608M Shares 332,610 Share Price $7.84 Est. Cost/Share — Unrealized @ Report Date —
DYN DYNE THERAPEUTICS INC 0.1%
Value $2.252M Shares 107,252 Share Price $21.00 Est. Cost/Share — Unrealized @ Report Date —
CG CARLYLE GROUP INC 0.0%
Value $742K Shares 23,600 Share Price $31.44 Est. Cost/Share — Unrealized @ Report Date —
TWLO TWILIO INC 0.0%
Value $684K Shares 2,021 Share Price $338.45 Est. Cost/Share — Unrealized @ Report Date —
PGNY PROGYNY INC 0.0%
Value $159K Shares 3,755 Share Price $42.34 Est. Cost/Share — Unrealized @ Report Date —